Annovis Bio Files 8-K on Financials and Personnel

Ticker: ANVS · Form: 8-K · Filed: May 13, 2025 · CIK: 1477845

Annovis Bio, Inc. 8-K Filing Summary
FieldDetail
CompanyAnnovis Bio, Inc. (ANVS)
Form Type8-K
Filed DateMay 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, officer-changes, director-changes, exhibits

Related Tickers: ANVS

TL;DR

Annovis Bio dropped an 8-K on May 13th covering financials and exec changes. Check it out.

AI Summary

Annovis Bio, Inc. filed an 8-K on May 13, 2025, reporting on results of operations and financial condition, director/officer changes, and financial statements. The filing covers events as of May 9, 2025, and includes information on their principal executive offices in Malvern, PA.

Why It Matters

This 8-K filing provides crucial updates on Annovis Bio's financial health and any changes in its leadership, which are important for investors to assess the company's stability and future direction.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting on standard corporate events and financial information, not indicating any immediate or significant risks.

Key Players & Entities

  • Annovis Bio, Inc. (company) — Registrant
  • May 9, 2025 (date) — Earliest event reported date
  • Malvern, PA (location) — Principal Executive Offices
  • 101 Lindenwood Drive, Suite 225 (address) — Principal Executive Offices Address

FAQ

What specific financial results are being reported in this 8-K?

The filing indicates that 'Results of Operations and Financial Condition' are being reported, but the specific details of these results are not provided in the provided text snippet.

Were there any changes in directors or officers reported?

Yes, the filing explicitly lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item of information covered.

What is the exact date of the earliest event reported in this filing?

The earliest event reported is dated May 9, 2025.

Where are Annovis Bio's principal executive offices located?

Annovis Bio's principal executive offices are located at 101 Lindenwood Drive, Suite 225, Malvern, PA 19355.

What is the Commission File Number for Annovis Bio, Inc.?

The Commission File Number for Annovis Bio, Inc. is 001-39202.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Annovis Bio, Inc. (ANVS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.